Comparison of endometrial thickness in freeze embryo transfer (ET) with the use of gonadotropin-releasing hormone (GnRH-a) agonists

Comparison of endometrial thickness in freeze embryo transfer (ET) with and without the use of gonadotropin-releasing hormone (GnRH) with taking estradiol

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N104

Enrollment

Registered

2018-10-07

Start date

2018-10-17

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: The intervention group, in addition to the estradiol tablet, will receive an antagonist gonadotropin-releasing hormone in 0.1 mg injection(manufactured by Iran Hormones Inc). Intervent

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Less than or equal to 42 years old The FSH level is less than 10 ml/mIU

Exclusion criteria

Exclusion criteria: Patients with asthma, systemic diseases and digestive disorders

Design outcomes

Primary

Measure	Time frame
Rate of fertile. Timepoint: The beginning and end of the study. Method of measurement: Using Ultrasound machine.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Fassihi

Kermanshah University of Medical Sciences

Drfassihi92@gmail.com+98 34276309

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026